Rapid Dose Therapeutics Corp. (CSE:DOSE)

Market Cap	27.70M
Revenue (ttm)	2.09M
Net Income (ttm)	-5.40M
Shares Out	131.89M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	500
Average Volume	44,087
Open	0.2100
Previous Close	0.2000
Day's Range	0.2100 - 0.2100
52-Week Range	0.1250 - 0.3250
Beta	-0.21
RSI	51.12
Earnings Date	Jun 27, 2025

About Rapid Dose Therapeutics

Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies designed to enhance patient outcomes in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system to rapidly release active molecule into the blood stream, such as pharmaceuticals, emulsified oils, and over-the-counter medicines; QuickStrip energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12 in the system; and QuickStrip sleep that delivers melatonin in the system, as well as dental products....

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Mark Upsdell
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: DOSE

Financial Performance

In 2024, Rapid Dose Therapeutics's revenue was 2.09 million, an increase of 104.34% compared to the previous year's 1.02 million. Losses were -5.40 million, 25.5% more than in 2023.